FIELD: medicine.
SUBSTANCE: present group of inventions relates to medicine, namely to oncology, and concerns the treatment of cancer. For this purpose, cancer patients who are deficient in the isomer of the enzyme N-myristoyltransferase 2 (NMT2) are identified. Treatment of this group of patients is carried out by administering an NMT inhibitor or NMT1 isoenzyme.
EFFECT: this provides an increase in the effectiveness of treatment of this group of patients, since cancer deficient in NMT2 is most sensitive to treatment with NMT inhibitors.
16 cl, 8 tbl, 38 ex, 42 dwg
| Title |
Year |
Author |
Number |
| SYNTHETIC LETHALITY AND THE TREATMENT OF CANCER |
2012 |
- Bertom Lyuk G.
- Boshamp Ervan
- Perinpanayagam Konganig Maneka Ann
- Yap Chuiee
|
RU2665952C2 |
| COMBINED IMMUNOTHERAPEUTIC APPROACH TO CANCER TREATMENT |
2015 |
|
RU2716821C2 |
| PHARMACEUTICAL COMBINATIONS FOR TREATING A MALIGNANT TUMOR |
2017 |
- Klinghoffer, Richard
- Dey, Joyoti
|
RU2726367C2 |
| MITOSIS INHIBITORS FOR INTENSIFICATION OF APOPTOSIS PROCESS IN THERAPY |
2009 |
- Tankvist Brajan Dzh.
- Voker Dunkan Kh.
- Vosner Richard Donal'D
|
RU2519145C2 |
| ANTIBODIES AGAINST CCR7 RECEPTOR FOR CANCER TREATMENT |
2006 |
- Mun'Os Kall'Ekha Sesilija
- Al'Fonso Peres Manuehl' Khesus
- Lopes Khiral' Sonia
|
RU2404808C2 |
| SYNERGISTIC COMBINATIONS OF AURISTANE |
2015 |
|
RU2717570C2 |
| SMALL MOLECULES FOR TREATMENT OF CANCER, INHIBITION OF CHEMOKINE ACTIVITY AND/OR INDUCTION OF CELL DEATH |
2020 |
- Peled, Amnon
- Abraham Karni, Michal
- Eizenberg, Orly
|
RU2814917C2 |
| TREATMENT OF B-CELLULAR MALIGNANT TUMORS USING ANTI-CD40L ANTIBODIES IN COMBINATION WITH ANTI-CD20 ANTIBODIES AND/OR BY CHEMOTHERAPY AND RADIOTHERAPY |
2000 |
- Khanna Nabil
- Kharikharan Kandasami
|
RU2305561C2 |
| COMBINATION OF CHEKPOINT-KINASE 1 INHIBITORS AND WEE 1 KINASE INHIBITORS |
2011 |
- Dejvis Kertis D.
- Gros Stefan
|
RU2627841C2 |
| TREATMENT OF CANCER, USING ANTIBODY TO SEMAPHORIN 4D IN COMBINATION WITH EPIGENETIC MODULATING AGENT |
2018 |
- Evans, Elizabet
- Smit, Ernest S.
- Zauderer, Moris
|
RU2783535C2 |
